How should dexamethasone (Decadron) be used for an acute migraine attack, including appropriate dosing, timing relative to abortive therapy, and contraindications?

Dexamethasone for Acute Migraine

Add dexamethasone 10 mg IV or IM as a single dose to your standard abortive therapy (NSAID + triptan or metoclopramide) to reduce headache recurrence within 72 hours of emergency department discharge. Dexamethasone does not improve acute pain relief but prevents the return of moderate-to-severe headache in approximately 1 out of every 9 patients treated 1, 2.

When to Use Dexamethasone

Dexamethasone is an adjunctive therapy, not a primary abortive agent. The 2025 AHS emergency department guideline recommends dexamethasone IV may be offered (Level C) 3, while the most recent 2025 American College of Physicians guideline does not specifically address corticosteroids for acute migraine 4. However, multiple high-quality meta-analyses consistently demonstrate benefit for preventing recurrence 1, 2.

Use dexamethasone when:

• Treating moderate-to-severe migraine in the ED or urgent care setting
• Patient has history of frequent headache recurrence after initial treatment
• Status migrainosus (prolonged migraine >72 hours)
• Incomplete pain relief with initial abortive therapy
• Higher baseline disability from the migraine 5

Dosing

Give dexamethasone 10 mg as a single dose, either IV or IM 5, 6.

A 2023 head-to-head trial definitively showed that 16 mg provides no additional benefit over 4 mg when combined with metoclopramide 7. The trial was stopped early for futility, with sustained headache relief occurring in 34% of the 4 mg group versus 41% of the 16 mg group (not statistically significant). Most historical studies used 10 mg, which remains the most commonly cited dose 5.

Do not use doses higher than 10 mg—you're adding cost and potential adverse effects without improving outcomes 7.

Timing and Administration

• Administer dexamethasone after or concurrent with your primary abortive therapy (not as monotherapy)
• Give as a single dose before ED discharge
• Onset of recurrence prevention effect occurs over 24-72 hours post-discharge 1, 2

The 2016 AHS guideline states dexamethasone "should be offered" (Level B) to prevent headache recurrence 6, based on multiple Class I studies showing a 26% relative risk reduction in recurrence (absolute risk reduction ~10%, NNT=9) 1.

What Dexamethasone Does NOT Do

Dexamethasone does not provide acute pain relief in the ED 1. A meta-analysis of 7 trials showed no difference in immediate pain reduction compared to placebo (weighted mean difference 0.37,95% CI -0.20 to 0.94) 1. Its benefit is specifically in reducing the likelihood of moderate-to-severe headache returning within 72 hours after you send the patient home.

Alternative Corticosteroid: Methylprednisolone Acetate

A 2019 trial compared long-acting methylprednisolone acetate 160 mg IM (which remains active for 14 days) versus dexamethasone 10 mg IM 8. Methylprednisolone acetate provided no advantage—patients reported 3.3 headache days in the week after discharge versus 3.0 days with dexamethasone, with more injection site reactions 8. Stick with dexamethasone.

Contraindications and Cautions

Standard corticosteroid contraindications apply:

• Active systemic infection (relative contraindication)
• Uncontrolled diabetes (single dose rarely problematic)
• Recent live vaccine administration
• Known hypersensitivity

Adverse effects from a single dose are minimal and similar to placebo 1, 2. The systematic reviews found adverse effects were "infrequent, mild, and transient" 2.

Clinical Algorithm

1. Treat the acute migraine first with standard abortive therapy per 2025 ACP guidelines 4:

   • Moderate-severe: Triptan + NSAID (or acetaminophen if NSAID contraindicated)
   • Alternative: Metoclopramide 10 mg IV for ED patients

2. Add dexamethasone 10 mg IV or IM as a single dose before discharge if:

   • Patient has history of recurrence, OR
   • Prolonged/severe attack (status migrainosus), OR
   • Incomplete response to initial therapy

3. Counsel patient that dexamethasone reduces risk of headache returning over next 2-3 days but won't make the current headache go away faster

4. Ensure follow-up plan including preventive therapy discussion if attacks are frequent (≥4 per month) 4

Common Pitfalls

• Don't use dexamethasone as monotherapy—it has no acute abortive effect 1
• Don't exceed 10 mg—higher doses don't work better 7
• Don't use opioids (hydromorphone, morphine) as first-line ED migraine therapy—the 2025 AHS guideline states hydromorphone "must not be offered" (Level A) 3, and the 2025 ACP guideline explicitly states "do not use opioids" 4
• Don't forget to address medication overuse headache risk—counsel patients about thresholds (≥10 days/month for triptans, ≥15 days/month for NSAIDs) 4